Abstract
No public abstract is available from the verified source records.
Gisli G Einarsson, Andrew J Lee, Zina Alfahl, Lauren Kerrigan, Joseph A Eustace, Sinéad Weldon, Barry J Plant, J Stuart Elborn, Clifford C Taggart, Marcus A Mall, Michael M Tunney
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
10.1034/j.1399-3003.2000.16d30.x · 2000
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations
10.1164/rccm.200812-1845pp · 2009
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment
10.1016/j.jcf.2023.11.010 · 2024
The cystic fibrosis lung microbiome
10.1513/annalsats.201306-159mg · 2014
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial
10.1183/13993003.02443-2024 · 2025
Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers
10.1136/thoraxjnl-2015-207235 · 2016
Changes in cystic fibrosis airway microbiota at pulmonary exacerbation
10.1513/annalsats.201211-107oc · 2013
Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis
10.1136/thx.2010.137281 · 2011
Longitudinal airway microbiota profiling in cystic fibrosis patients enrolled in the CFMATTERS clinical trial
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1016/s1569-1993(17)30168-6 · 2017
Microbial epidemiology of the cystic fibrosis airways: past, present, and future
10.1055/s-0042-1758732 · 2023
No additional external references are available.